Point72 Asia (Singapore)’s Marinus Pharmaceuticals, Inc MRNS Stock Holding History

Point72 Asia (Singapore)’s Portfolio MRNS Stock Details MRNS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-20,779	Closed	-$11.1K	–	1276
2024 Q4	$11.1K	Buy	20,779 +1,501	+8%	+$1.05K	﹤0.01%	731
2024 Q3	$33.9K	Sell	19,278 -35,600	-65%	-$49.7K	0.01%	748
2024 Q2	$64.2K	Buy	+54,878	New	+$137K	0.01%	587

Point72 Asia (Singapore)'s MRNS Position: Q1 2025 in Review

Point72 Asia (Singapore) sold out of Marinus Pharmaceuticals, Inc (MRNS) in Q1 2025, closing a stake of 20,779 shares — an estimated $11.1K sold.

Point72 Asia (Singapore) first reported a position in MRNS in Q2 2024 and held it in 3 quarters. The position peaked at $64.2K in Q2 2024. 0 funds tracked by Wall St. Rank hold MRNS as of Q1 2025.

Point72 Asia (Singapore) reported no remaining Marinus Pharmaceuticals, Inc position as of Q1 2025 after selling out during the quarter.
Point72 Asia (Singapore) sold 20,779 Marinus Pharmaceuticals, Inc shares in Q1 2025, an estimated $11.1K.
Point72 Asia (Singapore) first reported a position in Marinus Pharmaceuticals, Inc in Q2 2024 and held it in 3 quarters.
Point72 Asia (Singapore)'s Marinus Pharmaceuticals, Inc position peaked at $64.2K in Q2 2024.
0 funds tracked by Wall St. Rank held Marinus Pharmaceuticals, Inc as of Q1 2025.

Based on Point72 Asia (Singapore)'s 13F filing for Q1 2025, filed 15 May 2025.